June 2026 Pricing the Next Wave for CVD Secondary Prevention: A Value-Centric Lens based on Historical Market Rewards Read More
April 2026 Value-Informed Price Estimates for Disease-Modifying Therapies in Primary Progressive Multiple Sclerosis Read More